Key findings Related Stories High doses of caffeine from energy drinks cause cardiovascular harm New study uses sleep monitoring and AI to detect Alzheimer's Moderate coffee intake may support heart health, AHA says Within six months of starting GLP-1 therapy, the rate of hypotensive events increased from 8.7% to 10.2% The increased risk remained significant at 12 months, with hypotensive events rising from 13.6% to 14.3% Adults age 65 and older accounted for 53% of hypotensive events despite representing 37% of the study population Patients with Type 2 diabetes made up 75% of those experiencing hypotensive episodes but only 63% of the overall cohort In secondary analyses, the scientists found that weight loss alone did not explain the increased risk, suggesting other mechanisms of action may be at play Below is a Q&A with study senior author Dr

These therapies should never be positioned as replacements for established antihypertensive agents such as ACE inhibitors, ARBs, or calcium channel blockers
Get Our Exercises of the Month: Read Our Newsletter
You should stop using RYBELSUS 2 months before you plan to become pregnant are breastfeeding or plan to breastfeed
QuickMD is fundamentally different from the compounded-GLP-1 shopping funnels that dominate this catalog: its a live video telehealth appointment booking platform, and the public funnel is an appointment-scheduling form rather than a clinical questionnaire
Myth #5: Higher Doses Always Work Better Fact: Research doesn't support the assumption that doubling or tripling the dose proportionally increases benefits